107 results
Page 5 of 6
6-K
EX-99.1
52qcnw3b42wbxjen9c3
27 Oct 21
Evaxion Biotech Announces Filing of Registration Statement in the U.S for Proposed Follow-on Public Offering to Raise Additional Capital
4:29pm
F-1
qsmx32de5lz66s ck
26 Oct 21
Registration statement (foreign)
7:02am
6-K
EX-99.1
cwtik
25 Oct 21
Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
6:00am
6-K
EX-99.1
86g l6zongax
13 Aug 21
Current report (foreign)
4:06pm
6-K
EX-99.2
372rkjxsdal4
13 Aug 21
Current report (foreign)
4:06pm
6-K
EX-99.1
l5c3utjv
12 Aug 21
Evaxion Biotech Announces Q2 2021 Financial Results and Provides Business Update
9:09am
6-K
EX-99.1
c81ip
8 Jul 21
Evaxion Biotech Reports Data from Phase 1/2a Trials of EVX-01 and EVX-02
7:00am
6-K
EX-99.1
e8haaq m5haimwqfd
25 Jun 21
Evaxion Develops Method to Enhance AI Drug Development with Deep Probabilistic Programming
4:30pm
DRS
u19zvx7b p4
25 Jun 21
Draft registration statement
12:00am
6-K
EX-99.1
axcqgoyyaz
3 Jun 21
Current report (foreign)
4:31pm
6-K
EX-99.1
qzxnngg
26 May 21
Evaxion Biotech Appoints Lars Holtug to the Board of Directors
4:31pm
6-K
EX-99.1
7vzf6w owx2tkd
14 May 21
Current report (foreign)
4:05pm
6-K
EX-99.2
cs8f ffnz2lv
14 May 21
Current report (foreign)
4:05pm
6-K
EX-99.1
i2hgeri5w12qk8kpv10z
13 May 21
Evaxion Biotech Announces Q1 2021 Financial Results and Provides Business Update
7:30am
6-K
EX-99.1
je4a04 fs7uals5
3 May 21
Notice of annual general meeting
8:49am
6-K
EX-99.5
75a1o8yo1jcznrj60n3
3 May 21
Notice of annual general meeting
8:49am
20-F
9vw6phrqnnxb4g1arz
7 Apr 21
Annual report (foreign)
4:31pm
6-K
EX-99.1
wqk6l9a4d io9p
6 Apr 21
Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update
7:31am
424B4
15fhxhlgqjqhea443a
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1/A
9t9wz t9je5kz38
1 Feb 21
Registration statement (foreign) (amended)
4:56pm